303
Views
4
CrossRef citations to date
0
Altmetric
Cornea

Selective Laser Trabeculoplasty for Steroid-Induced Ocular Hypertension following Endothelial Keratoplasty

ORCID Icon, , , &
Pages 1362-1365 | Received 29 Mar 2022, Accepted 02 Jun 2022, Published online: 22 Aug 2022

References

  • Liesenborghs I, Schouten JSAG, Berendschot TTJM, Beckers HJM, Nuijts RMMA, Visser N, Webers CAB. Risk factors for the development of ocular hypertension after keratoplasty: a systematic review. Cornea. 2020;39(3):394–402. doi:10.1097/ICO.0000000000002209.
  • Woo J-H, Ang M, Htoon HM, Tan D. Descemet membrane endothelial keratoplasty versus descemet stripping automated endothelial keratoplasty and penetrating keratoplasty. Am J Ophthalmol. 2019;207:288–303. doi:10.1016/j.ajo.2019.06.012.
  • Moisseiev E, Varssano D, Rosenfeld E, Rachmiel R. Intraocular pressure after penetrating keratoplasty and Descemet's stripping automated endothelial keratoplasty. Can J Ophthalmol. 2013;48(3):179–185. doi:10.1016/j.jcjo.2013.01.003.
  • Zhou Y, Pruet CM, Fang C, Khanna CL. Selective laser trabeculoplasty in steroid-induced and uveitic glaucoma. Can J Ophthalmol. 2021;S0008-4182(21)00176–9. doi:10.1016/j.jcjo.2021.05.006. Online ahead of print.
  • Gazzard G, Konstantakopoulou E, Garway-Heath D, Garg A, Vickerstaff V, Hunter R, Ambler G, Bunce C, Wormald R, Nathwani N, LiGHT Trial Study Group, et al. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Lancet. 2019;393(10180):1505–1516. doi:10.1016/S0140-6736(18)32213-X.
  • Zhou Y, Aref AAA. A review of selective laser trabeculoplasty: recent findings and current perspectives. Ophthalmol Ther. 2017;6(1):19–32. doi:10.1007/s40123-017-0082-x.
  • Maier AKB, Pilger D, Gundlach E, Winterhalter S, Torun N. Long-term results of intraocular pressure elevation and post-dmek glaucoma after descemet membrane endothelial keratoplasty. Cornea. 2021;40(1):26–32. doi:10.1097/ICO.0000000000002363.
  • Beiran I, Rootman DS, Trope GE, Buys YM. Long-term results of transscleral Nd:YAG cyclophotocoagulation for refractory glaucoma postpenetrating keratoplasty. J Glaucoma. 2000;9(3):268–272. doi:10.1097/00061198-200006000-00011.
  • Subramaniam K, Price MO, Feng MT, Price FW. Micropulse transscleral cyclophotocoagulation in keratoplasty eyes. Cornea. 2019;38(5):542–545. doi:10.1097/ICO.0000000000001897.
  • Nakakura S, Imamura H, Nakamura T. Selective laser trabeculoplasty for glaucoma after penetrating keratoplasty. Optom Vis Sci. 2009;86(4):e404–e406. doi:10.1097/OPX.0b013e318199d226.
  • Van Meter WS, Allen RC, Waring GO, Stulting RD. Laser trabeculoplasty for glaucoma in aphakic and pseudophakic eyes after penetrating keratoplasty. Arch Ophthalmol. 1988;106(2):185–188. doi:10.1001/archopht.1988.01060130195023.
  • Kramer TR, Noecker RJ. Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes. Ophthalmology. 2001;108(4):773–779. doi:10.1016/s0161-6420(00)00660-6.
  • Zhou R, Sun Y, Chen H, Sha S, He M, Wang W. Laser trabeculoplasty for open-angle glaucoma: a systematic review and network meta-analysis. Am J Ophthalmol. 2021;229:301–313. doi:10.1016/j.ajo.2020.07.046.
  • Maier A-KB, Wolf T, Gundlach E, Klamann MKJ, Gonnermann J, Bertelmann E, Joussen AM, Torun N. Intraocular pressure elevation and post-DMEK glaucoma following Descemet membrane endothelial keratoplasty. Graefes Arch Clin Exp Ophthalmol. 2014;252(12):1947–1954. doi:10.1007/s00417-014-2757-5.
  • Kornmann HL, Gedde SJ. Glaucoma management after corneal transplantation surgeries. Curr Opin Ophthalmol. 2016;27(2):132–139. doi:10.1097/ICU.0000000000000237.
  • Anders L-M, Gatzioufas Z, Grieshaber MC. Challenges in the complex management of post-keratoplasty glaucoma. Ther Adv Ophthalmol. 2021;13:25158414211031397. doi:10.1177/25158414211031397.
  • Ishioka M, Shimazaki J, Yamagami J, Fujishima H, Shimmura S, Tsubota K. Trabeculectomy with mitomycin C for post-keratoplasty glaucoma. Br J Ophthalmol. 2000;84(7):714–717. doi:10.1136/bjo.84.7.714.
  • Nagar M, Ogunyomade A, O’Brart DPS, Howes F, Marshall J. A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma. Br J Ophthalmol. 2005;89(11):1413–1417. doi:10.1136/bjo.2004.052795.
  • Katz LJ, Steinmann WC, Kabir A, Molineaux J, Wizov SS, Marcellino G, SLT/Med Study Group. Selective laser trabeculoplasty versus medical therapy as initial treatment of glaucoma: a prospective, randomized trial. J Glaucoma. 2012;21(7):460–468. doi:10.1097/IJG.0b013e318218287f.
  • Lee JW, Chan CW, Wong MO, Chan JC, Li Q, Lai JS. A randomized control trial to evaluate the effect of adjuvant selective laser trabeculoplasty versus medication alone in primary open-angle glaucoma: preliminary results. OPTH. 2014;8:1987–1992. doi:10.2147/OPTH.S70903.
  • Lai JSM, Chua JKH, Tham CCY, Lam DSC. Five-year follow up of selective laser trabeculoplasty in Chinese eyes. Clin Exp Ophthalmol. 2004;32(4):368–372. doi:10.1111/j.1442-9071.2004.00839.x.
  • Corneal endothelial cell loss associated with selective laser trabeculoplasty. 2021. ARVO Annual Meeting Abstract.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.